CDTVSNRSN• 3 Months (Normalized)
CDT vs NRSN (CDT Equity Inc. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Jun 27 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CDT Performance $0.14
-97.68%
CDT Equity Inc.
Normalized Baseline0.00%
NRSN Performance $7.4
+942.25%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-1039.93 pts
NRSN outperforming by 1039.93 percentage points
CDTNRSN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CDT NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | CDT Price | CDT Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $0.14 | -97.68% | $7.40 | +942.25% | -1039.93% |
| Sep 22, 2026 | $0.14 | -97.56% | $7.18 | +911.27% | -1008.83% |
| Sep 21, 2026 | $0.15 | -97.36% | $6.62 | +832.39% | -929.75% |
| Sep 18, 2026 | $0.17 | -97.02% | $6.35 | +794.37% | -891.39% |
| Sep 17, 2026 | $0.19 | -96.74% | $6.72 | +846.48% | -943.22% |
| Sep 16, 2026 | $0.20 | -96.60% | $6.49 | +814.08% | -910.68% |
| Sep 15, 2026 | $0.20 | -96.52% | $7.03 | +890.14% | -986.66% |
| Sep 14, 2026 | $0.22 | -96.24% | $6.90 | +871.83% | -968.07% |
| Sep 11, 2026 | $0.25 | -95.71% | $0.35 | -51.13% | -44.58% |
| Sep 10, 2026 | $0.35 | -94.08% | $0.33 | -53.24% | -40.84% |
| Sep 09, 2026 | $0.60 | -89.71% | $0.40 | -43.52% | -46.19% |
| Sep 08, 2026 | $0.62 | -89.42% | $0.42 | -41.13% | -48.29% |
| Sep 04, 2026 | $0.63 | -89.28% | $0.51 | -28.03% | -61.25% |
| Sep 03, 2026 | $0.75 | -87.15% | $0.40 | -43.38% | -43.77% |
| Sep 02, 2026 | $0.91 | -84.39% | $0.41 | -42.11% | -42.28% |
Page 1 of 5